Cargando…

Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance

Conventional 'nonselective' nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for the treatment of pain and inflammation; however, the potential gastrointestinal risks associated with their use can be a cause for concern. In response to the adverse effects that can accompany no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borer, Jeffrey S, Simon, Lee S
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833977/ https://www.ncbi.nlm.nih.gov/pubmed/16168077 http://dx.doi.org/10.1186/ar1794

Ejemplares similares

Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs
por: Scheiman, James M, et al.
Publicado: (2005)

Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors
por: Rostom, Alaa, et al.
Publicado: (2009)

Selective COX-2 inhibitors, NSAIDs and cardiovascular events – is celecoxib the safest choice?
por: Howes, Laurence Guy
Publicado: (2007)

Balancing the gastrointestinal benefits and risks of nonselective NSAIDs
por: Peura, David A, et al.
Publicado: (2005)

Relative Value of the NSAIDs, Including COX-2 Inhibitors and Meloxicam
por: Curtiss, Frederic R.
Publicado: (2006)

Gastrointestinal Bleeding Rates Among Managed Care Patients Newly Started on COX-2 Inhibitors or Nonselective NSAIDs
por: Stockl, Karen, et al.
Publicado: (2005)

Network Meta-Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury
por: Yang, Man, et al.
Publicado: (2015)

Selective COX-2 inhibitor continues to be a safe alternative in patients with nonselective NSAIDs hypersensitivity
por: Thalappil, Sherin, et al.
Publicado: (2022)

Gastrointestinal toxicity among patients taking selective COX‐2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case–control study
por: Bakhriansyah, Mohammad, et al.
Publicado: (2017)

Balancing gastrointestinal benefit–risk in individuals who are prescribed NSAIDs for arthritis
por: Bijlsma, Johannes W. J.
Publicado: (2010)

An observational study of the discrediting of COX-2 NSAIDs in Australia: Vioxx or class effect?
por: Parkinson, Lynne, et al.
Publicado: (2011)

Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis
por: Latimer, Nicholas, et al.
Publicado: (2009)

New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation
por: Bokhtia, Riham M., et al.
Publicado: (2023)

COX2 genetic variation, NSAIDs, and advanced prostate cancer risk
por: Cheng, I, et al.
Publicado: (2007)

Treatment and chemoprevention of NSAID-associated gastrointestinal complications
por: Frech, Edward J, et al.
Publicado: (2009)

Risk of gastrointestinal bleeding and cardiovascular events due to NSAIDs in the diabetic elderly population
por: Kim, Jungmee, et al.
Publicado: (2015)

COX-2: Where are we in 2003? - Distinction from NSAIDs becoming blurred
por: Day, Richard
Publicado: (2003)

Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors
por: Mukherjee, Debabrata, et al.
Publicado: (2003)

Adverse Effects of COX-2 Inhibitors
por: Sharma, Jagdish N., et al.
Publicado: (2005)

The importance of provocation tests with COX2 inhibitors on patients with a history of cross-hypersensitivity to non-steroidal anti-inflammatory (NSAIDs)
por: Gonçalves, Tania Tavares
Publicado: (2015)

Review of the cardiovascular safety of COXIBs compared to NSAIDS
por: Moodley, I
Publicado: (2008)

Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Gastroprotective NSAIDs on the Gastrointestinal Tract: A Narrative Review
por: Sohail, Rohab, et al.
Publicado: (2023)

Management of NSAID Associated Upper Gastrointestinal Problems
por: Cryer, Byron
Publicado: (2005)

Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity
por: McEvoy, L., et al.
Publicado: (2021)

New horizons in the roles and associations of COX-2 and novel natural inhibitors in cardiovascular diseases
por: Chen, Wujun, et al.
Publicado: (2021)

Prescription Pattern of NSAIDs and the Prevalence of NSAID-induced Gastrointestinal Risk Factors of Orthopaedic Patients in Clinical Practice in Korea
por: Lee, Sung-Hun, et al.
Publicado: (2011)

NSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen Species
por: Ghosh, Rajeshwary, et al.
Publicado: (2015)

COX-2 inhibitory NSAID-induced multiple stenosis in the small intestine diagnosed by double-balloon endoscopy
por: Ueno, Yasuaki, et al.
Publicado: (2016)

Efficacy and tolerability of naproxen/esomeprazole magnesium tablets compared with non-specific NSAIDs and COX-2 inhibitors: a systematic review and network analyses
por: Datto, Catherine, et al.
Publicado: (2013)

Advances in antitumor effects of NSAIDs
por: Zhang, Zhen, et al.
Publicado: (2018)

Exploring the role of COX-2 in Alzheimer's disease: Potential therapeutic implications of COX-2 inhibitors
por: Moussa, Nathalie, et al.
Publicado: (2023)

COX-2 Inhibitors and Gastric Cancer
por: Wang, Zhen, et al.
Publicado: (2014)

Are gastrointestinal signals the principal guides to human appetite and energy balance?
por: Borer, Katarina T.
Publicado: (2023)

Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use
por: Straube, Sebastian, et al.
Publicado: (2009)

Gastrointestinal-Sparing Effects of Novel NSAIDs in Rats with Compromised Mucosal Defence
por: Blackler, Rory, et al.
Publicado: (2012)

Prescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritis
por: Lanas, Angel, et al.
Publicado: (2011)

Radiolabeled COX-2 Inhibitors for Non-Invasive Visualization of COX-2 Expression and Activity — A Critical Update
por: Laube, Markus, et al.
Publicado: (2013)

Effects of the Highly COX-2-Selective Analgesic NSAID Etoricoxib on Human Periodontal Ligament Fibroblasts during Compressive Orthodontic Mechanical Strain
por: Kirschneck, Christian, et al.
Publicado: (2019)

A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors
por: Brænne, Ingrid, et al.
Publicado: (2017)

Expression and Molecular Regulation of the Cox2 Gene in Gastroenteropancreatic Neuroendocrine Tumors and Antiproliferation of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
por: Gao, Feng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mam4c84btji3p1ftqncgf3f3dq